Endocrine system cancer

While the cancer is active or treatment is ongoing, medical records confirming the diagnosis of a malignant neoplasm of the endocrine system are the foundation of the 100% rating. Pathology reports, biopsy results, imaging studies, and oncology treatment records showing surgery, radiation, or chemotherapy all document that the condition and its treatment are present.

For the mandatory examination that takes place six months after treatment ends, records showing whether the cancer has recurred locally or spread are critical. Imaging results, follow-up oncology notes, and lab work that address recurrence or metastasis directly speak to those criteria. If no recurrence or metastasis is found, records and personal statements describing any lasting symptoms or functional problems from the cancer or its treatment help establish what residual disabilities remain, since the rating would then shift to those residuals.